Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
-
Synergy Pharmaceuticals Announces Proposed Public Offering of Common Stock
-
Canaccord Genuity Skeptical on 72 mcg Linzess Efficacy, Diarrhea; Maintains 'Buy'
-
Canaccord Genuity Maintains Bullish View on Synergy Pharmaceuticals (SGYP) as Plecanatide Shows Higher Efficacy, Safety Versus Linzess
-
Synergy Pharmaceuticals to Present at Canaccord Genuity 36th Annual Growth Conference
-
Synergy Pharmaceuticals to Present at the Canaccord Genuity Growth Conference
-
Pre-Open Stock Movers 06/23: (GDOT) (PHMD) (FIT) (DRI) Higher; (CTP) (VICL) (MELA) Lower (more...)
-
Notable 52-Week Highs and Lows 6/19: (CAG) (SGYP) (RHT) High; (HWAY) (PVA) (PVCT) Low
-
Notable 52-Week Highs and Lows 6/18: (SGYP) (BMRN) (RDUS) High; (HERO) (AAVL) Low
-
Synergy (SGYP) PT Lifted to $19 at Canaccord Genuity; 'This Thang Don't Stank'
-
Pre-Open Stock Movers 06/18: (LMNS) (DGLY) (BMRN) Higher; (HERO) (RATE) (ORCL) Lower (more...)
-
UPDATE: Canaccord Genuity Starts Synergy Pharmaceuticals (SGYP) at Buy, PT $11
-
Synergy Pharma (SGYP) Announces $90M Common Offering
-
Streetinsider.com's Hot Lunchtime Reads 08/30: (YGE) (FB) (SGYP) (S) (YELP)

